Communication between tyrosine kinase pathway and myosin light chain kinase pathway in smooth muscle

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 271, Issue 4 40-4, 1996, Pages

  Jin, Najia ^a   Siddiqui, Rafat A ^b   English, Denis ^b   Rhoades, Rodney A ^b  

^a INDIANA UNIVERSITY   (United States)

^b NONE

Author keywords

genistein; mitogen activated protein kinase; tyrosine phosphatase; vanadate; vascular smooth muscle

Indexed keywords

ENZYME INHIBITOR; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN KINASE; PHENYLEPHRINE; PHOSPHATASE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; VANADATE SODIUM;

ANIMAL TISSUE; AORTA; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CROSSING OVER; ENZYME ACTIVATION; FETAL CALF SERUM; IMMUNOBLOTTING; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PULMONARY ARTERY; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 33750843512     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.271.4.h1348     Document Type: Article

References (35)

1. Akiyama, T., and H. Ogawara. Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol. 201: 362-370, 1991.
2. Auger, K. R., L. A. Serunian, S. R. Soltoff, P. Libby, and L. C. Cantley. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell 57: 167-175, 1989.
3. Berk, B. C., R. W. Alexander, T. A. Brock, M. A. Gimbrone, and R. C. Webb. Vasoconstriction: a new activity for platelet-derived growth factor. Science Wash. DC 232: 87-90, 1986
4. Bilder, G. A., J. A. Krawiec, K. McVety, A. Gazit, C. Gilon, R. Lyall, A. Zilberstein, A. Levitzki, M. H. Perrone, and A. B. Schrieber. Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells. Am. J. Physiol. 260 (Cell Physiol. 29): C721-C730, 1991.
5. Blenis, J. Signal transduction via the MAP kinases: proceed at your own RSK. Proc. Natl. Acad. Sci. USA 90: 5889-5892, 1993.
6. Cerione, R. A. Reconstitution of receptor/GTP-binding protein interactions. Biochim. Biophys. Acta 1071: 473-501, 1991.
7. Choi, O. H., R. S. Adelstein, and M. A. Beaven. Secretion from rat basophilic RBL-2H3 cells is associated with dephosphorylation of myosin light chains by myosin light chain kinase as well as phosphorylation by protein kinase C. J. Biol. Chem. 269: 536-541, 1994.
8. Cobb, M. H., and E. J. Goldsmith. How MAP kinases are regulated. J. Biol. Chem. 270: 14843-14846, 1995.
9. Cook, S. J., and F. McCormick. Inhibition by c-AMP of Ras-dependent activation of Raf. Science Wash DC 262: 1069-1072. 1993.
10. Cooper, J. A., B. M. Sefton, and T. Hunter. Diverse mitogenic agents induce the phosphorylation of two related 42000-dalton proteins on tyrosine in quiescent chick cells. Mol. Cell. Biol. 4: 30-37, 1984.
11. DiSalvo, J., A. Steusloff, L. Semenchuk, S. Satoh, K. Kolquist, and G. Pfitzer. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem. Biophys. Res. Commun. 190: 968-974, 1993.
12. Egan, S. E., and R. A. Weinberg. The pathway to signal achievement. Nature Lond. 365: 781-783, 1993.
13. Fujio, Y., F. Yamada, K. Takahasi, and N. Shibata. Responses of smooth muscle cells to platelet-derived growth factor are inhibited by herbimycin-A tyrosine kinase inhibitor. Biochem. Biophys. Res. Commun. 195: 79-83, 1993.
14. Homma, Y., H. Sakamot, M. Tsunoda, M. Aoki, T. Takenawa, and T. Ooyama. Evidence for involvement of phospholipase C-gamma 2 in signal transduction of platelet-derived growth factor in vascular smooth muscle cells. Biochem. J. 290: 649-653, 1993.
15. Hunter, T., and J. A. Cooper. Protein-tyrosine kinases. Annu. Rev. Biochem. 54: 897-930, 1985.
16. Jin, N., C. S. Packer and R. A. Rhoades. Pulmonary arterial hypoxic contraction: signal transduction. Am. J. Physiol. 263 (Lung Cell. Mol. Physiol. 7): L73-L78, 1992.
17. Kamm, K. E., and J. T. Stull. The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu. Rev. Pharmacol. Toxicol. 25: 593-620, 1985.
18. Khalil, R. A., and K. G. Morgan. PKC-mediated redistribution of mitogen-activated protein kinase during smooth muscle cell activation. Am. J. Physiol. 265 (Cell Physiol. 34): C406-C441, 1993.
19. Koide, M., Y. Kawahara, T. Tsuda, Y. Ishida, K. Shii, and M. Yokoyama. Endothelin-1 stimulates tyrosine phosphorylation and the activities of two mitogen-activated protein kinases in cultured vascular smooth muscle cells. J. Hypertens. 10: 1173-1182, 1992.
20. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature Lond. 227: 680-685, 1970.
21. L'Allemain, G. Deciphering the MAP kinase pathway. Prog. Growth Factor Res. 5: 291-334, 1994.
22. Leevers, S. J., H. F. Paterson, and C. J. Marshall. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membranes. Nature Lond. 369: 411-414, 1994.
23. Levitzki, A., and A. Gazit. Tyrosine kinase inhibition: an approach to drug development. Science Wash. DC 267: 1782-1788, 1995.
24. Marquardt, B., D. Frith, and S. Stabel. Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro Oncogene 9: 3213-3218, 1994.
25. Marx, J. Two major signal pathways linked. Science Wash. DC 262: 988-989, 1993
26. Merkel, L. A., L. M. Rivera, D. J. Colussi, and M. H. Perron. Inhibition of EGF-induced vasoconstriction in isolated rabbit aortic rings with the tyrosine kinase inhibitor RG50864. Biochem. Biophys. Res. Commun. 192: 1319-1326, 1993.
27. Molloy, C. J., D. S. Taylor, and H. Weber. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J. Biol. Chem. 268: 7338-7345, 1993.
28. Persechini, A., K. E. Kamm, and J. T. Stull. Different phosphorlated forms of myosin in contracting tracheal smooth muscle. J. Biol. Chem. 261: 6293-6299, 1986.
29. Schlessinger, J., and A. Ullrich. Growth factor signaling by receptor tyrosine kinases. Neuron 9: 383-391, 1992.
30. Sefton, B. M., T. Hunter, K. Beemon, and W. Eckhart. Evidence that the phosphorylation of tyrosine is essential for cellular transformation by Rous sarcoma virus. Cell 120: 807-816, 1980.
31. Stokoe, D., S. G. Macdonald, K. Cadwallader, M. Symons, and J. F. Hancock. Activation of Raf as a result of recruitment to the plasma membrane. Science Wash. DC 264: 1463-1467, 1994.
32. Thorburn, J., and A. Thorburn. The tyrosine kinase inhibitor, genistein, prevents alpha-adrenergic-induced cardiac muscle cell hypertrophy by inhibiting activation of the Ras-MAP kinase signaling pathway. Biochem. Biophys. Res. Commun. 202: 1586-1591, 1994.
33. Tsuda, T., Y. Kawahara, K. Shii, M. Koide, Y. Ishida, and M. Yokoyama. Vasoconstrictor-induced protein-tyrosine phosphorylation in cultured vascular smooth muscle cells. FEBS Lett. 285: 44-48, 1991.
34. Yang, S. G., M. Saifeddine, and M. D. Hollenberg. Tyrosine kinase inhibitors and the contractile action of epidermal growth factor-urogastrone and other agonists in gastric smooth muscle. Can. J. Physiol. Pharmacol. 70. 85-93, 1992.
35. Zhong, Y. Mediation of PACAP-like neuropeptide transmission by coactivation of Ras/Raf, and cAMP signal transduction pathways in Drosophila. Nature Lond. 375: 588-592, 1995.